MolecularHealth
announced today that it has opened a new office in the greater Boston
metro area, at the Riverside Center in Newton, Mass. Run by Chief
Commercial Officer Laura Housman, the Boston location will house members
of the company’s commercial and business development teams, among others.
“Boston is a hotbed of cutting-edge science, and a major biotech hub,”
said Housman. “As we work towards generating adoption of our oncology
treatment decision support offering over the coming months, it’s
important that we have a presence in Boston, where many of our current
and potential partners and customers are located.”
Dr. Lloyd Everson, CEO of MolecularHealth, added, “As we get closer to
the official launch of our next generation sequencing and TreatmentMAP™
service offering to oncologists, pathologists and the biopharma
industry, we are continuing to add key personnel and build out our
infrastructure. A physical location in the Boston area was a logical
next step for the company, and I look forward to additional growth as we
enter the market.”
MolecularHealth recently announced the opening
of its U.S. headquarters and clinical lab, co-located in The
Woodlands, Texas. Following a number of key new hires to its executive
team in Texas, the company expects to fill several additional positions
for its Boston office, including a marketing director and health
economist.
ABOUT MOLECULARHEALTH
MolecularHealth delivers on the promise of personalized, precision
medicine. By using advanced proprietary information technologies to sift
through terabytes of genetic and molecular test findings in a fraction
of the time needed for current manual analysis, MolecularHealth provides
doctors and patients with faster, more accurate insights into the role
genes play in the progression and treatment of an individual’s cancer.
Eight years in development by a multidisciplinary team of doctors,
scientists and IT experts, MolecularHealth works in partnership with
some of the world’s leading healthcare and information technology
companies, including the University of Texas MD Anderson Cancer Center,
SAP AG, and the U.S. Food and Drug Administration (FDA). The company has
headquarters in The Woodlands, Texas and Heidelberg, Germany. Visit www.molecularhealth.com for
more information.
Contacts
Gregory FCA
Jessica Attanasio
Associate Vice President
610-228-2112
Jessica@GregoryFCA.com
Copyright (2014) Business Wire.
All Rights Reserved.
Open all references in tabs: [1 – 4]